Company Introduction
Subsidiary Enterprises
Company Introduction
Home > General Introduction > Company Introduction

Shanghai Lansheng Corporation, the former Shanghai Stationery & Sporting Goods Import & Export Corporation, which was established on January 1, 1983. On February 4 th of 1994, the Company was listed in Shanghai Stock Exchange (stock code: 600826). In the course of its twenty years' growth, Shanghai Lansheng Corporation has focused its development on four main business areas, including trade and industry, finance, real estate and biophar.

The company covers its business over 130 countries and regions with more than 20 major categories such as footwear, sporting gears, stationery, traveling articles, suitcases or bags, sporting wear, musical instruments, toys, large-scale mechanism and so on, which built up good oversea business relationship with around 2000 customers, including some well-known international brands as MOLTEN, WILSON, CONVERSE, ESPRIT, GAP, MH, MHI, REPLAY, MARUBENI, and DAEWOO. In recent years, our annual turnover has been a steady upwards of 200 million US dollars, reputing as a top exporter in Shanghai .


Lansheng takes great importance to quality management and applies to the international quality management system. Many subsidiaries have been awarded the international quality certification as ISO9001 and TQA.

At present, Lansheng Corp. completely partially controls 30 own factories besides other 300 appointed producing partners, which are reliable and stable resources for our business. The Company has its own registered brands, including FORWARD, HISPO, LANHUA, NIEER, KOFA, ETERNA, PIONEER, SNOWFLAKE, LARK, and GREAT WALL etc.

In the financial area, Shanghai Lansheng Corp. invested hundreds of million on finance such as Hai Tong Securities and Bank of Communication etc.

In real estate area, the Company is the owner of Shanghai Lansheng Real Estate Co., Ltd. Towering on the HuaiHai Road , Lansheng Building is the first project undertaken by Shanghai Lansheng Real Estate Co, Ltd.

Recently, co-operated with overseas biopharmaceutical experts, the Company has developed its own bio-medical products on independent intellectual property, and also jointly invested RMB 686 million in Zhangjiang hi-tech industry area with CITIC Pacific, Hong Kong , to establish Shanghai CP Guojian Pharmaceutical Co. Ltd.

Copyright 2006@ Shanghai Lansheng Corporation All Right Resvered
沪ICP备17047569号 | Designed by:DSH